Vaccinations in HIV-infected children;Vaccins classiques et moins classiques chez l'enfant infecté par le VIH

Revue Medicale de Liege

Volumn 60, Issue 12, 2005, Pages 923-930

  Serpe, J N ^a   Schmitz, V ^b   Lepage, Ph ^b,c  

^a ULg ^*  (Belgium)

^b Clinique Adjoint   (Belgium)

^c Service de Pediatrie   (Belgium)

Author keywords

AIDS; Children; Vaccination

Indexed keywords

BCG VACCINE; CHICKENPOX VACCINE; DIPHTHERIA TETANUS TOXOID; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; MEASLES VACCINE; ORAL POLIOMYELITIS VACCINE; PNEUMOCOCCUS VACCINE; RUBELLA VACCINE; VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BCG VACCINATION; CHICKENPOX; CHILD; DIPHTHERIA; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; HEPATITIS A; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION SENSITIVITY; MEASLES; POLIOMYELITIS; PRACTICE GUIDELINE; REVIEW; RISK BENEFIT ANALYSIS; RUBELLA; STREPTOCOCCUS INFECTION; TETANUS; TUBERCULOSIS; VACCINATION; WORLD HEALTH ORGANIZATION;

CHILD; HIV INFECTIONS; HUMANS; VACCINATION;

EID: 29944432045     PISSN: 00353663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Laforce FM.- Vaccination des enfants infectés par le virus de l'immunodéficience humaine (VIH). Afr Med Santé, 1990, 47, 34-36.
2. Dabis F, Lepage P, Msellati P, et al.- Vaccination de routine et infection par le VIH de l'enfant et de l'adulte. Cahiers Santé, 1994, 4, 173-182.
3. Courpotin C, Lasfargues G.- L'infection à VIH de l'enfant. Impact Médecin-Guide Sida, 1997, 141-152.
4. WHO/OMS.- Programme spécial de lutte contre le syndrome d'immunodéficience acquise (sida) et programme élargi de vaccination. Déclaration conjointe. Consultation sur le virus de l'immunodéficience humaine (VIH) et la vaccination systématique des enfants. Wkly Epidemiol Rec/Relevé Épidémiol Hebd, 1987, 62, 297-299.
5. Kroon FP, Van Dissel JT, de Jong JC, van Furth R.- Antibody response to influenza, tetanus and pneumoccal vaccines in HIV-seropositive individuals in relation to the number of CD4+ lymphocytes. AIDS, 1994, 8, 469-476.
6. De Martino M, Podda A, Galli L, et al.- Acellular pertussis vaccine in children perinatal human immunodeficiency virus type-1 infection. Vaccine, 1997, 1235-1238
7. Donovan R, Moore E, Bush CE, et al.- Changes in plasma HIV RNA levels and CD4 cell counts after vaccination in pédiatrie patients. AIDS, 1997, 11, 1054-1056
8. Center for Disease Control and Prevention.- Recommendations of the Advisory Committee on Immunization Practices (ACIP): use of vaccines and immune globulins in persons with altered immunocompetence. Morb Mortal Wkly Rec, 1993, 42, (RR-4), 1-18.
9. Begue P, Bouvet E, Vilde JL, et le CSHPE- Vaccin: vaccinations des enfants nés de mère VIH-positive. Bull Épidémiol Hebd, 1990, 29, 101.
10. Kaczorek M.- Les vaccins recombinants. La Lettre de l'Infectiologue, 1992, 7, 194-198
11. Ryder RW, Oxtoby MJ, Mvula M, et al.- Safety and immunogenicity of bacille Calmette-Guerin, diphteria-tetanus-pertussis, and oral polio vaccines in newborn children in Zaire infected with human immunodeficiency virus type. J Pediatr, 1993, 122, 697-702.
12. Center for Disease Control and Prevention.- 1997 USPH/IDSA Prevention of Opportunistic Infections Working Group. USPH/IDSA Guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. Morb Mortal Wkly Rec, 1997, 46 (RR-12), 1-48.
13. Peters VB, Sood SK.- Immunity to Haemophilus influenzae type b polysaccharide capsule in children with human immunodeficiency virus infection immunized with a single dose of Haemophilus vaccine. J Pediatr, 1994, 125, 74-77.
14. Madhi SA, Petersen K, Khoosal M et al.- Reduced effectiveness of Haemophilus influenzae type b conjugate vaccine in children with a high prevalence of human immunodeficiency virus type 1 infection. Pediatr Infect Dis J, 2002, 21, 315-321.
15. Rutstein RM, Rudy BJ, Cnaan A.- Response of human immunodeficiency virus-exposed and -infected infants to Haemophilus influenzae type b conjugate vaccine. Arch Pediatr Adolesc Med, 1996, 150, 838-841
16. Peters VB, Mayer L, Sperber KE.- Correlation of clinical parameters and immunological function with human immunodeficiency virus plasma viremia in children. Viral Immunol, 1999, 12, 139-148
17. Gibb D, Giacomelli A, Masters J et al.- Persistance of antibody responses to Haemophilus influenzae type b polysaccharide conjugate vaccine in children with vertically acquired human immunodeficiency virus infection. Pediatr Infect Dis J, 1996, 15, 1097-1101.
18. Read JS, Frasch CE, Rich K et al.- The immunogenicity of Haemophilus influenzae type b vaccines in children born to human immunodeficiency virus-infected women. Women and Infants Transmission Study Group. Pediatr Infect Dis J, 1998, 17, 391-397.
19. Saliou P, Plotkin S.- Perspectives en vaccinologie. Cahiers Santé, 1994, 4, 237-241.
20. Arrazola MP, de Juanes JR, Ramos JT, et al.- Hepatitis B vaccination in infants of mothers infected with human immunodeficiency virus. J Med Virol, 1995, 45, 339-41.
21. Zuccotti GV, Riva E, Flumine P, et al.- Hepatitis B vaccination in infants of mothers infected with human immunodeficiency virus.,J Pediat, 1994, 125, 70-2.
22. Rutstein RM, Rudy B, Codispoti C, Watson B.- Response to hepatitis B immunization by infant exposed infants exposed to HIV. AIDS, 1994, 8, 1281-1284
23. Scolfaro C, Fiammengo P, Balba L, et al.- Hepatitis vaccination in HIV-1-infected children: double efficacy doubling the paediatric dose. AIDS, 1996, 10, 1169-1182
24. Krasinski K, Borkwski W.- Measles and measles immunity in children infected with human immunodeficiency virus. JAMA, 1989, 261, 2512-2516.
25. Rudy BJ, Rustein RM, Pinto-Mann J.- Response to measles immunisation in children infected with human immunodeficiency virus. J Pediatr, 1994, 125, 72-74.
26. Arpadi SM, Lauri E, Markowitz MD, et al.- Measles antibody in vaccinated human immunodeficiency virus type 1-infected children. Pediatrics, 1996, 97, 653-657.
27. Moss W J, Cutts F, Griffin DE.- Implications of the human immmunodeficiency virus epidemic for control and eradication of measles. Clin Infect Dis, 1999, 29, 106-112.
28. Lepage P, Dabis F, Msellati P et al.- Safety and immunogenicity of high-dose Edmonston-Zagreb measles vaccine in children with HIV-1 infection. A cohort study in Kigali, Rwanda. Am J Dis Child, 1992, 146, 550-7.
29. Cutts FT, Mandala K, St Louis M et al.- Immunogenicity of high-titer Edmonston-Zagreb measles vaccine in human immunodeficiency virus-infected children in Kinshasa, Zaire. J Infect Dis, 1993, 671, 1418-21.
30. Walter EB, Katz SL, Bellini WJ.- Measles immunity in HIV-infected children. Pediatr AIDS HIV Infect, 1994, 5, 300-304
31. Brena AE, Cooper ER, Cabral HJ, Pelton SI.- Antibody response to measles and rubella vaccine by children with HIV infection. J Acquir Immune Deci Syndr, 1993, 6, 1125-1129
32. Palumbo P, Hoyt L, Demasio K, et al.- Population-based study of measles and measles immunization in human immunodeficiency virus infected children. Pediatr Infect Dis J, 1992, 11, 1008-1014.
33. Bouchaud O.- Vaccination chez les sujets infectés par le VIH. La Lettre de l'Infectiologue, 1996, 11, 564-565.
34. American Academy of Pediatrics. Committee on Infectious Diseases and Committee on Pediatric AIDS.-Measles immunization in HIV-infected children. Pediatrics, 1999, 103, 1057-60
35. Centers for Disease Control and Prevention.- Measles pneumonitis following measles-mumps-rubella vaccination of a patient with HIV infection: 1993. MMWR Morb Mortal Wkly Rep, 1996, 45, 603-606
36. Kabra SK, Lodha R, Seth V- Tuberculosis in children- what has changed in last 20 years? Indian J Pediatr, 2002, 69, suppl 1, 5-10
37. WHO/QMS.- BCG et infection à VIH chez l'enfant. Wkly Epidemiol Rec/Relevé Épidémiol Hebd, 1992, 67, 129-136
38. Quinn TC.- Interactions of the human immunodeficiency virus and tuberculosis and the implications for BCG vaccination. Rev Infect Dis, 1989, II (suppl. 2), S379-384.
39. Lallemant-Le Cœur S, Lallemant M, Cheynier D, et al.- Bacillus Calmette-Guerin immunization in infants born to HIV-1-seropositive mothers. AIDS, 1991, 5, 195-199
40. Scarpellini Campos JM, Simonetti JM, Pone MV.- Disseminated BCG infection in HIV-infected children: case report and review. Pediatric AIDS and HIV infection: Fetus to adolescent, 1996, 7, 429-432.
41. Dormont J et groupe d'experts.- Prise en charge des personnes atteintes par le sida. Rapport 1996. Paris: Flammarion, 1996: 323 p.
42. WHO/OMS.- Vaccins antivaricelleux. Note d'information de l'OMS. Wkly Epidemiol Rec/Relevé Épidémiol Hebd, 1998, 73, 241-248.
43. Larussa P, Steinberg S, Gershon A.- Varicella vaccine for immunocompromised children : results of collaborative studies in the United States and Canada. J Infect Dis, 1996, 174 (suppl. 3), S320-323
44. Jones N, Huebner R, Khoosal M, et al.- The impact of HIV on Streptococcus pneumoniae bacteraemia in a South African population. AIDS, 1998, 12, 2177-2184
45. Ahmed F, Steinhoff MC, Rodreguez-Barradas MC et al.- Effect of human immunodeficiency virus type 1 infection on the antibody response to a glycoprotein conjugate pneumococcal vaccine: results from a randomized trial. J Infect Dis, 1996, 173, 83-90
46. King JC, Vink PE, Farley JJ et al.- Comparison of the safety and the immunogenicity of a pneumococcal conjugate with a licensed polysaccharide vaccine in human immunodeficiency virus and non-human immunodeficiency virus-infected children. Pediatric Infecti Dis J, 1996, 15, 192-196.
47. Nachman S, Kim S, King J, et al.- Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants with human immunodeficiency virus type 1 infection. Pediatrics, 2003, 112, 66-73.
48. Lepage P, De Mol P.- Epidémiologie et prévention des infections à méningocoques en Europe. Journées Parisiennes de Pédiatrie 2002. Paris, Octobre 2002. Flammarion Médecine- Sciences, pp 165-172.
49. Bose A, Coen P, Tully J, et al.- Effectiveness of meningococcal conjugate vaccine in teenagers in England. Lancet, 2003, 361, 675-6.
50. Ramsay ME, Andrews N, Kaczmarski EB, Miller E.- Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England. Lancet, 2001, 357, 195-6.
51. Schmitz V, Florkin B, Lepage P.- Reactogenicity and immunogenicity of a meningococcal group C conjugate vaccine in HIV-infected children. 43rd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Chicago, USA, September 14-17, 2003. Abstr#D-1860. G-1646.